Dyadic Logo Current.jpg
Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
06. Januar 2025 08:30 ET | Dyadic International, Inc.
Dyadic Provides Business Update Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
Dyadic Logo Current.jpg
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
12. November 2024 16:05 ET | Dyadic International, Inc.
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue...
Dyadic Logo Current.jpg
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
04. November 2024 16:30 ET | Dyadic International, Inc.
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Dyadic Logo Current.jpg
Dyadic Expands Global Presence with Participation in Key Industry Events
09. Oktober 2024 08:00 ET | Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of...
Dyadic Logo Current.jpg
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
23. September 2024 09:50 ET | Dyadic International, Inc.
JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient,...